91 related articles for article (PubMed ID: 17707061)
21. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation.
Fujihara A; Kurooka M; Miki T; Kaneda Y
Cancer Immunol Immunother; 2008 Jan; 57(1):73-84. PubMed ID: 17602226
[TBL] [Abstract][Full Text] [Related]
22. IN VIVO STUDY OF POTENTIAL MECHANISMS OF MACROPHAGE REPOLARIZATION ON THE BACKGROUND OF TUMOR GROWTH.
Fedosova N; Chumak A; Cheremshenko N; Karaman O; Symchych T; Voyeykova I
Exp Oncol; 2024 May; 46(1):30-37. PubMed ID: 38852055
[TBL] [Abstract][Full Text] [Related]
23. Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation.
Park JM; Terabe M; Donaldson DD; Forni G; Berzofsky JA
Cancer Immunol Immunother; 2008 Jun; 57(6):907-12. PubMed ID: 18004566
[TBL] [Abstract][Full Text] [Related]
24. Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model.
Hagenaars M; Ensink NG; Eggermont AM; van der Velde EA; van de Velde CJ; Fleuren GJ; Kuppen PJ
Cancer Immunol Immunother; 2000 Jan; 48(10):561-8. PubMed ID: 10630308
[TBL] [Abstract][Full Text] [Related]
25. AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity.
Schnoegl D; Hiesinger A; Huntington ND; Gotthardt D
Curr Opin Immunol; 2023 Dec; 85():102397. PubMed ID: 37931499
[TBL] [Abstract][Full Text] [Related]
26. Killer T cells show their kinder side.
Klenerman P; Ogg G
Nature; 2018 Mar; 555(7698):594-595. PubMed ID: 29595806
[No Abstract] [Full Text] [Related]
27. A milestone method to make natural killer T cells.
Metelitsa LS
Nat Biotechnol; 2024 May; ():. PubMed ID: 38744945
[No Abstract] [Full Text] [Related]
28. Ultimate Secreting Structure.
Med Exam (Phila); 1842 Aug; 5(35):557-558. PubMed ID: 38119343
[No Abstract] [Full Text] [Related]
29. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
Front Genet; 2023; 14():1109991. PubMed ID: 36992705
[No Abstract] [Full Text] [Related]
30. Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells.
Bugide S; Janostiak R; Wajapeyee N
Trends Cancer; 2018 Aug; 4(8):553-566. PubMed ID: 30064663
[TBL] [Abstract][Full Text] [Related]
31. IL-21 Signaling in Immunity.
Leonard WJ; Wan CK
F1000Res; 2016; 5():. PubMed ID: 26966515
[TBL] [Abstract][Full Text] [Related]
32. Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
Dahlberg CI; Sarhan D; Chrobok M; Duru AD; Alici E
Front Immunol; 2015; 6():605. PubMed ID: 26648934
[TBL] [Abstract][Full Text] [Related]
33. IL-21: a pleiotropic cytokine with potential applications in oncology.
Croce M; Rigo V; Ferrini S
J Immunol Res; 2015; 2015():696578. PubMed ID: 25961061
[TBL] [Abstract][Full Text] [Related]
34. Perspectives in drug development for metastatic renal cell cancer.
Basu B; Eisen T
Target Oncol; 2010 Jun; 5(2):139-56. PubMed ID: 20689997
[TBL] [Abstract][Full Text] [Related]
35. Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.
Capitini CM; Fry TJ; Mackall CL
Am J Immunol; 2009 Jan; 5(3):65-83. PubMed ID: 20182648
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration.
Hara I; Nagai H; Miyake H; Yamanaka K; Hara S; Micallef MJ; Kurimoto M; Gohji K; Arakawa S; Ichihashi M; Kamidono S
Cancer Gene Ther; 2000 Jan; 7(1):83-90. PubMed ID: 10678360
[TBL] [Abstract][Full Text] [Related]
38. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response.
Furukawa J; Hara I; Nagai H; Yao A; Oniki S; Fujisawa M
J Urol; 2006 Sep; 176(3):1198-203. PubMed ID: 16890725
[TBL] [Abstract][Full Text] [Related]
40. Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.
Suchorska WM; Dams-Kozlowska H; Kazimierczak U; Wysocki PJ; Mackiewicz A
Expert Opin Biol Ther; 2011 Dec; 11(12):1555-67. PubMed ID: 21995459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
